Evidence map›Paper›PMID 33893998›Full record

ReviewArchives of pharmacal research2021

Phytochemistry and pharmacological activity of the genus artemisia.

Dheeraj Bisht, Deepak Kumar, Dharmendra Kumar, Kamal Dua, Dinesh Kumar Chellappan

Open access · bronzeAbstract readReview
In one paragraph

Review in Archives of pharmacal research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
27.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 211 citations in OpenAlex.

  1. Review
  2. Article
  3. DietaryAnimals : an open access journal from MDPI · 2026
    Article
  4. Selected Cannabinoids, Cannabimimetic Agents andPharmaceuticals (Basel, Switzerland) · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Low-ThujoneMolecules (Basel, Switzerland) · 2026
    Article
  9. Unveiling the multifaceted potential ofJournal of pharmaceutical analysis · 2026
    Review
  10. Review
  11. Metal and Metal Oxide Nanoparticles UsingPlants (Basel, Switzerland) · 2026
    Review
  12. Article
  13. Pharmaceuticals (Basel, Switzerland) · 2026
    Article
  14. Review
  15. Bioactive Profiling ofThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Essential Oil from the Aerial Parts ofMolecules (Basel, Switzerland) · 2025
    Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 3 countries.

Dheeraj BishtDepartment of Pharmaceutical Sciences, Sir J. C. Bose Technical Campus Bhimtal, Kumaun University, Nainital, Uttarakhand, 263136, India. dheeraj.bisht729@gmail.com.
Deepak KumarSchool of Pharmaceutical Sciences, Shoolini University, Solan, H.P., 173 229, India.
Dharmendra KumarDepartment of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, UCSI University, 56000, Kuala Lumpur, Malaysia.
Kamal DuaSchool of Pharmaceutical Sciences, Shoolini University, Solan, H.P., 173 229, India.
Dinesh Kumar ChellappanDepartment of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, 57000, Kuala Lumpur, Malaysia.
International Medical University · MYKumaun University · INShoolini University · INUCSI University · MYUniversity of Technology Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artemisia and its allied species have been employed for conventional medicine in the Northern temperate regions of North America, Europe, and Asia for the treatments of digestive problems, morning sickness, irregular menstrual cycle, typhoid, epilepsy, renal problems, bronchitis malaria, etc. The multidisciplinary use of artemisia species has various other health benefits that are related to its traditional and modern pharmaceutical perspectives. The main objective of this review is to evaluate the traditional, modern, biological as well as pharmacological use of the essential oil and herbal extracts of Artemisia nilagirica, Artemisia parviflora, and other allied species of Artemisia. It also discusses the botanical circulation and its phytochemical constituents viz disaccharides, polysaccharides, glycosides, saponins, terpenoids, flavonoids, and carotenoids. The plants have different biological importance like antiparasitic, antimalarial, antihyperlipidemic, antiasthmatic, antiepileptic, antitubercular, antihypertensive, antidiabetic, anxiolytic, antiemetic, antidepressant, anticancer, hepatoprotective, gastroprotective, insecticidal, antiviral activities, and also against COVID-19. Toxicological studies showed that the plants at a low dose and short duration are non or low-toxic. In contrast, a high dose at 3 g/kg and for a longer duration can cause toxicity like rapid respiration, neurotoxicity, reproductive toxicity, etc. However, further in-depth studies are needed to determine the medicinal uses, clinical efficacy and safety are crucial next steps.

Indexed as

ArtemisiaAntiviral AgentsCOVID-19 Drug TreatmentHumansMedicine, TraditionalPhytotherapyPlant ExtractsPlant OilsAntiviral AgentsPlant ExtractsPlant OilsArtemisiaCOVID-19Essential oilPharmacological activityPhytochemical constituentsSesquiterpenesToxicological studies

Identifiers

PMID33893998
PMCPMC8067791
OpenAlexW3153853143

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.